Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 26, 2000

View Archived Issues

Intracel's phase III trial for bladder cancer approved by FDA

Vion updates clinical progress and development agreements

Guilford reacquires rights to Gliadel Wafer

MitoKor and UCSD receive BioSTAR grant for osteoarthritis research

LF-16-0687MS reduces brain edema and neurological severity scores in closed head trauma

ASA 2000: binding, functional and physicochemical properties of TRK-820 and TAN-684

Human studies confirm excellent safety and suitable pharmacokinetics of parecoxib

Phase II trial with EBV vaccine begins, triggering milestone payment to Aviron

Bradykinin B2 antagonist effective in rat model of head trauma

Remicade recommended for approval in Europe for broader application

CHEST 2000: anti-TNF MAb improves survival, reduces organ dysfunction in sepsis

FDA grants priority review status to Genelabs' NDA for new lupus therapy

Organon characterizes water-soluble general anesthetic advanced to early clinical trials

Update on proposed Novo Nordisk demerger

SmithKline Beecham's combination pediatric vaccine approved in E.U.

Novel immunosuppressants revealed by Japanese lab

Thiadiazole STAT6 activation inhibitors designed at Sumitomo

Dainippon describes new, water-soluble neutrophil elastase inhibitors

Bayer discloses sulfonamides and their use in the treatment of HCMV infections

U.S. patent covers new series of GH secretagogues from Novo Nordisk

Preparation and use of protease inhibitor series particularly useful in bone diseases

Novel treatments for labor pain revealed in recent patent by AstraZeneca

Caspase 3 inhibitors from Merck Frosst demonstrate antiischemic activity

Astex Technology and Janssen enter second research collaboration

Researchers discover potential new target for antidepressant drugs

Gaucher's disease therapy receives European orphan drug status

Inflammatory and autoimmune disease treatment enters phase I testing

Leukemia treatment designated an orphan drug in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...
US lawmakers demand that Kennedy be held accountable
BioWorld
As the systematic dismantling of the U.S. vaccine schedule escalates, the demands to hold Health and Human Services Secretary Robert Kennedy accountable are...
Heartbeam wins appeal, gains FDA clearance
BioWorld MedTech
Management is beaming with delight at Heartbeam Inc. as the company's appeal strategy paid off with U.S. FDA clearance for its synthetic 12-lead electrocardiogram...